This double-blind placebo controlled crossover pilot trial will test the hypothesis that
prazosin, an alpha-1 adrenergic receptor antagonist, reduces craving for their drug of choice
in cocaine-dependent and alcohol-dependent veterans. Both the study medication period and the
placebo period are each 4 weeks in duration.
Phase:
N/A
Details
Lead Sponsor:
US Department of Veterans Affairs VA Office of Research and Development